Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Colgate To Buy Hello Brand, Expand Natural Products Line

Published 01/23/2020, 09:17 PM
Updated 07/09/2023, 06:31 AM

Colgate-Palmolive Company (NYSE:CL) has agreed to acquire Hello Products LLC, a leading oral care brand in the United States that produces eco-friendly and organic products. Hello’s products include adult and kids toothpaste, mouth rinse, toothbrushes and floss. The brand’s products, which have a distinct position in the market, are extremely popular with young consumers and across the broader segment. Further, the brand fully complements the company’s Tom’s of Maine and Colgate brands.

Colgate plans to finance the deal with a combination of cash and debt. The company anticipates closing the transaction by February 2020. Following the completion of the acquisition, Hello’s founder Craig Dubitsky and CEO Lauri Kien Kotcher will continue to lead the brand.

The company expects the acquisition to be flat to a penny dilutive to 2020 earnings per share, after including transaction costs. The terms of the deal were not disclosed.

Colgate is on track with product innovation and in-store implementation, which have been key aspects of its growth strategies for years. The company’s innovation strategy is focused on growing adjacent categories and product segments.

Further, it remains focused on the premiumization of its Oral Care portfolio through major innovation. The company has a solid innovation pipeline in the next few quarters, which includes the launch of Optic White. Additionally, it continues to expand Naturals toothpaste and prescription diet. In fact, the Naturals range is a key area of focus for the company in personal and home care categories.



Also, Colgate continues to expand portfolio by introducing pharmacy brands like elmex and meridol to newer markets. It is impressed with the performance of its professional skincare businesses — Elta MD and PCA Skin — in spas and dermatologists. In addition, the company is on track to expand the premium skincare portfolio with the buyout of the Filorga skincare business. It is also expanding product availability through the e-commerce channel.

We note that, shares of this Zacks Rank #2 (Buy) company have gained 3.2% in the past three months, compared with the industry’s growth of 0.8%.

3 Other Stocks to Consider

Helen of Troy Limited (NYSE:EL) presently has an expected long-term earnings growth rate of 9.3% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Procter & Gamble Company (NYSE:PG) has a long-term earnings growth rate of 7.5% and carries a Zacks Rank #2.

The Estee Lauder Companies Inc. (NYSE:EL) has a long-term earnings growth rate of 12.8%. Currently, it carries a Zacks Rank #2.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>



The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Helen of Troy Limited (HELE): Free Stock Analysis Report

Colgate-Palmolive Company (CL): Free Stock Analysis Report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.